drugset / Trial / NCT07348653
A Study of MG2512 Injection in Participants With Advanced Solid Tumors
NaSingle-groupOpen-labelTreatment
Summary
This is an open-label, multi-center, multiple dose Phase 1 study to evaluate the safety, tolerability, pharmacokinetics and efficacy of MG2512 injection in participants with advanced solid tumors.
Timeline
- Start
- 2026-03-18
- Primary completion
- 2026-12
- Completion
- 2027-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | MG2512 | Unknown | — | — |